Microreviews:

Microbial Cell, Vol. 3, No. 5, pp. 227 - 229; doi: 10.15698/mic2016.05.502

Translational repression in malaria sporozoites

Oliver Turque1, Tiffany Tsao1, Thomas Li1 and Min Zhang1,2

Download PDF download pdf
Show/hide additional information

    1 HIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY, USA.

    2 Department of Pathology, New York University School of Medicine, New York, NY, USA.

Keywords: Plasmodium, sporozoites, latency, eIF2α, UIS1, UIS2, translational repression.
Received originally: 14/02/2016 Accepted: 24/02/2016 Published: 05/04/2016

Correspondence:
Min Zhang, Dr.Min.Zhang@gmail.com

Conflict of interest statement:

The authors declare that no competing interest exists.
Please cite this article as: Oliver Turque, Tiffany Tsao, Thomas Li and Min Zhang (2016). Translational repression in malaria sporozoites. Microbial Cell 3(5): 227-229.

Malaria is a mosquito-borne infectious disease of humans and other animals. It is caused by the parasitic protozoan, Plasmodium. Sporozoites, the infectious form of malaria parasites, are quiescent when they remain in the salivary glands of the Anopheles mosquito until transmission into a mammalian host. Metamorphosis of the dormant sporozoite to its active form in the liver stage requires transcriptional and translational regulations. Here, we summarize recent advances in the translational repression of gene expression in the malaria sporozoite. In sporozoites, many mRNAs that are required for liver stage development are translationally repressed. Phosphorylation of eukaryotic Initiation Factor 2α (eIF2α) leads to a global translational repression in sporozoites. The eIF2α kinase, known as Upregulated in Infectious Sporozoite 1 (UIS1), is dominant in the sporozoite. The eIF2α phosphatase, UIS2, is translationally repressed by the Pumilio protein Puf2. This translational repression is alleviated when sporozoites are delivered into the mammalian host.

Plasmodium sporozoites are quiescent for several weeks in mosquito salivary glands while maintaining their infectivity. In stark contrast to the parasite’s continuous transcriptional changes in the liver (pre-erythrocytic) and blood (erythrocytic) stages in their vertebrate hosts, the sporozoite’s transcriptional program remains unchanged during the long period of time in mosquito salivary glands. The transcriptional and translational profiles of sporozoites and pre-erythrocytic stage parasites display significant lags in protein abundance relative to mRNA abundance, due to a global translational repression caused by the phosphorylation of eIF2α in salivary gland sporozoites.

Eukaryotic Initiation Factor 2 (eIF2), composed of α, β, γ subunits, recruits Met-tRNA and GTP to form a ternary complex that binds to ribosome, which initiates protein translation. GTP is then hydrolyzed, and the ribosome releases eIF2-GDP as an inactive binary complex. EIF2B, a guanine nucleotide exchange factor, subsequently converts eIF2-GDP to eIF2-GTP, which is required for another round of translational initiation. Phosphorylation of eIF2α blocks the recycling of eIF2-GDP to its translationally active eIF2-GTP form, thereby inhibiting global protein synthesis. The stalled mRNAs are then assembled as stress granules (messenger ribonucleoprotein complexes) in Plasmodium sporozoites. Activating Transcription Factor 4 (ATF4), a transcriptional activator of genes involved in the integrated stress response, is preferentially translated when eIF2α is phosphorylated in mammalian cells (Figure 1A). In Plasmodium, it is unknown if phosphorylation of eIF2α facilitates the preferential translation of select transcripts while repressing general translation initiation.

Figure 1 Latency in malaria sporozoites

FIGURE 1: Model illustrating translational repression in malaria sporozoites.

(A) Translational repression by eIF2α phosphorylation and Puf2. Puf2 stabilizes and inhibits translation of a group of mRNAs by binding to their 3' untranslated region. SAP1 stabilizes 38 uis mRNAs and non-uis mRNAs. EIF2α phosphorylation inhibits global protein synthesis.The stalled mRNAs are assembled into RNA granules.

(B) Regulation of eIF2α phosphorylation. Phosphorylation of eIF2α is controlled by the kinase UIS1 and the phosphatase UIS2. uis1 and uis2 transcripts are stabilized by SAP1, and the translation of uis2 is repressed by Puf2. UIS1 is dominant, and causes dormancy in Plasmodium sporozoites.

Plasmodium eIF2α kinase UIS1 (also termed eIK1) phosphorylates eIF2α in salivary gland sporozoites. Uis genes are a subset of thirty genes that are transcriptionally upregulated when sporozoites differentiate from the mosquito midgut to salivary glands. The eIF2α phosphatase is UIS2 in Plasmodium salivary glands sporozoites, where the uis1 and uis2 mRNAs are most abundant among the uis transcripts. Plasmodium Pumilio protein Puf2 contains a sequence-specific RNA binding domain and serves as a translational repressor of specific mRNAs by binding to their 3′-untranslated region. Puf2 inhibits translation of uis2, consequently rendering UIS1 dominant. This leads to a prevalence of phosphorylated eIF2α and global protein repression in sporozoites (Figure 1B).

Many liver stage messages, such as uis2 and uis4, bind to Puf2 and are translationally repressed and stabilized in sporozoites (Figure 1). The transcriptome and morphology of puf2(-) sporozoites in P. berghei and P. yoelii rodent malaria, transform into early liver stages. The transcript of uis1 is degraded in the puf2(-) sporozoites. The phenotype of the eIF2α kinase uis1(-) is similar to that of puf2(-). The eIF2α phosphatase uis2(-) sporozoites do not transform into liver stages but maintain their crescent sporozoite shapes after delivery to host cells. The phenotype of uis2(-) is adverse to that of uis1(-) and puf2(-).

Sporozoite Asparagine-rich Protein 1 (SAP-1) is essential for the stability of a group of thirty-eight mRNA transcripts in P. yoelli salivary gland sporozoites. The transcripts of many uis genes are quickly degraded at their 3’-ends, including uis1 and uis2. Additionally, in the sap1(-) sporozoite, some transcripts, including uis4, were shown to be quickly degraded at their 5’-ends. Thus, in the absence of SAP-1, genes that are essential to liver-stage development of the infectious sporozoite follow the pattern in which the 3’ and 5’ ends of the mRNA molecule are sequentially degraded.

Since UIS2 is essential for liver-stage development of sporozoites, we explored its function. In mammalian cells, Protein Phosphatase 1 (PP1) with its cofactor GADD34 or CReP mediates the dephosphorylation of eIF2α-P. However, GADD34 and CReP are absent in Plasmodium. Our data show that Plasmodium PP1 does not dephosphorylate Plasmodium eIF2α-P in sporozoites. Rather, UIS2 is the eIF2α-P phosphatase that directly binds to its substrate eIF2α-P. Our demonstration that UIS2 is a novel eIF2α-P phosphatase reveals another mechanism to control eIF2α dephosphorylation. Our findings also suggest that additional mechanisms have evolved to control eIF2α dephosphorylation in organisms that do not contain recognizable homologs of GADD34 or CReP.

UIS2 contains a conserved RVxF motif within its phosphatase domain (Figure 2). This motif is a putative PP1-binding motif. Although PP1 is not an eIF2α phosphatase in sporozoites, we do not exclude the possibility that Plasmodium PP1 might be an eIF2α phosphatase in other stages of the malaria life cycle. An interesting hypothesis requiring further investigation is that Plasmodium PP1 is recruited by UIS2. The redundant eIF2α phosphatase may result in rapid dephosphorylation of eIF2α during the sporozoite’s transition from its latent form to its active form.

Figure 2 Latency in malaria sporozoites

FIGURE 2: The RVxF motif in UIS2 phosphatase domain.

P. berghei UIS2 (1321 amino acids) contains a phosphatase domain (roughly residues 535-1054). The amino acids around RVxF motif in UIS proteins from P. berghei, P. yoelii, P. chabaudi, P. vivax, P. knowlesi, and P. falciparum are aligned. The cyan area shows the conserved phosphatase domain and the gray region shows the insertion in UIS2 relative to 1UTE (the best matching phosphatase in Protein Data Bank).

Plasmodium sporozoites remain latent in mosquito salivary glands until transmission to a host. The translational repression of liver stage messages such as uis2, uis3, and uis4 in sporozoites is correlated with the observation that these genes are not essential for the parasite’s sporozoite stage development. Liver stage messengers start to translate by the alleviation of translational repression. The initiation factor, eIF2α, is dephosphorylated in pre-erythrocytic stages where UIS2 is dominant. These parasites utilize continuous transcriptional changes for their pre-erythrocytic and erythrocytic stage development.

P. vivax infects humans and undergoes an especially dangerous type of latent morphology in the liver. Hypnozoites remain dormant in the liver of their host until they eventually cause a relapse of malaria. Though the transcriptional and translational profiles of hypnozoites are unknown, we speculate that translation is similarly repressed in hypnozoites, and that their latency is associated with eIF2α phosphorylation. One possibility is that UIS2 remains translationally repressed in hypnozoites until a signal (currently unknown) reactivates them.

ACKNOWLEDGMENTS

This work was supported by National Institutes of Health (grant AI108592) and Sao Paulo Research Foundation (FAPESP, grant 12/50399-4).

COPYRIGHT

© 2016

Creative Commons License
Translational repression in malaria sporozoites by Oliver Turque et al. is licensed under a Creative Commons Attribution 4.0 International License.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.

Close